$POLY

Company: PolyPid Ltd. Symbol: POLY Description: They are a clinical-stage pharmaceutical company focused on developing and commercializing novel, locally administered therapies using their transformational PLEX (Polymer-Lipid Encapsulation matriX) technology. Shares: 3.33 million Price Range: $21.00-$24.00 Trade Date: 3/23 Underwriter(s): Goldman Sachs, Cowen Co-Manager(s): Cantor, Raymond James, Oppenheimer & Co. Terms Added: 3-14-18 Link to S-1/A[…]